AVDL,Avadel Pharmaceuticals plc | Healthcare

Healthcare

AVDL

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Avadel Pharmaceuticals plcAVDL

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States.

Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy.

The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017.

Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Latest News >

JPMorgan launches in-house chatbot as AI-based research analyst, FT reports

Jul 25, 2024

July 26 (Reuters) - JPMorgan Chase ( JPM ) has begun rolling out a generative artificial intelligence (AI) product, telling employees that its own version of OpenAI's ChatGPT can do the work of a research analyst, the Financial Times reported on Friday. The lender, the biggest in the United States, has given employees of its asset and wealth management division...

Amundi's Q2 net inflows beat estimates on Asian contributions

Jul 25, 2024

PARIS (Reuters) - Amundi, Europe's biggest fund manager, posted better-than-expected quarterly inflows on Friday, driven by its Asian joint ventures amid a sustained demand for risk-averse products. Amundi's total assets under management (AUM) rose by 15.5 billion euros ($16.8 billion) in the second quarter to 2.16 trillion euros at end of June, setting a new record and reflecting growth of...

Swiss stocks - Factors to watch on July 26

Jul 25, 2024

July 26 - Here are some of the main factors that may affect Swiss stocks on Friday: HOLCIM Reports Q2 results slightly ahead of forecasts. COMPANY STATEMENTS AMS OSRAM ( AUKUF ) Second quarter earnings release due. FORBO HOLDING Confirms spring outlook for full year 2024. VONTOBEL Half-year earnings release due. SULZER Posts Order Intake Above 2 billion Swiss francs...

Mercedes-Benz narrows 2024 outlook for cars profit margin

Jul 25, 2024

(Reuters) -Mercedes-Benz on Friday narrowed its annual forecast for the profit margin in its core car division as the German luxury automaker continues to struggle amid model changeover and a subdued market environment in Asia. The company now expects an adjusted return on sales in the range of 10-11% this year, down from 10-12% expected before. Mercedes' cars division was...